For research use only — not for human consumption

Senna Research
← Back to catalog
FOXO4-DRI (Proxofim) research vial

Longevity & Cellular Research

In stock

FOXO4-DRI (Proxofim)

FOXO4-DRI is a synthetic peptide designed to disrupt FOXO4-p53 interactions and is studied in cellular senescence and aging pathway research models.

Professional pricing

Sign in or create a research account to see prices and add this material to your order. Access unlocks as soon as you create your account.

Sign in for pricing
  • In stock — ready to ship
  • Controlled handling
Shipment issuesWe do not accept returns on released material. Wrong item, damage, or a missing package is resolved directly.

Specifications

Product & molecular data

Lot & handling

SKU
SR-2191
Category
Longevity & Cellular Research
Storage
-20 °C, sealed, protected from light
Availability
In stock

Molecular

Sequence
Retro-inverso D-amino acid FOXO4 interaction peptide
Molecular formula
C176H291N59O40
Molecular weight
3757.4 g/mol
CAS number
2216447-90-1
Storage conditions
−20 °C sealed and desiccated, protected from light
Format
Lyophilized Vial

Analytics

Testing & quality

When a lot certificate is on file we report identity, purity, and appearance. We publish analytical data only — never dosing information or outcome claims.

01

RP-HPLC

Chromatographic purity against a qualified reference standard.

02

LC-MS / ESI-MS

Identity by observed versus theoretical molecular mass.

03

Karl Fischer / Loss on Drying

Residual moisture in lyophilized material.

04

Endotoxin & Bioburden

Contaminant screening on raw material and finished lots.

Read the Quality Statement →

Research background

Published research context

Summary of the published literature this reference material is used in.

01

Telomere Biology

Investigated in cell-culture models of telomere maintenance and replicative ageing.

02

Gene Expression

Studied for reported effects on transcriptional regulation in experimental systems.

03

Senescence Models

Referenced in literature examining cellular senescence markers in vitro.

FOXO4-p53 Interaction Research

FOXO4-DRI was developed to selectively interfere with the binding between FOXO4 and p53, a pathway associated with senescent cell survival [1]. Research models investigate how this disruption influences senescence-associated signaling and transcriptional regulation.

Cellular Senescence Models

Studies involving FOXO4-DRI examine senescent cell markers, apoptosis-related signaling, and stress-response pathways [2]. These investigations contribute to broader research into aging-associated cellular mechanisms.

Molecular Design and Specificity

The D-retro-inverso (DRI) design improves peptide stability and resistance to degradation, making it suitable for controlled pathway analysis [1].

Key Specs

  • Peptide class: DRI-modified signaling peptide
  • Research context: senescence, FOXO4-p53 signaling
  • References: PubMed [1,2]

Referenced Citations

  1. PubMed, FOXO4-DRI and senescent cells: https://pubmed.ncbi.nlm.nih.gov/28671688/
  2. PubMed, FOXO4 in aging research: https://pubmed.ncbi.nlm.nih.gov/29559565/

Related compounds

Mandatory research disclaimer

All materials on this site are sold as laboratory reagents for research use only. They are not drugs, foods, cosmetics, dietary supplements, or medical devices, and are not for human or veterinary use of any kind.

Senna Research makes no claims of safety or efficacy and provides no usage, dosing, or preparation guidance; we publish analytical data only.

These materials have not been evaluated or approved by the U.S. Food and Drug Administration for any use.